mCRP-Induced Focal Adhesion Kinase-Dependent Monocyte Aggregation and M1 Polarization, which was partially blocked by the C10M Inhibitor

Pastorello, Ylenia ORCID: https://orcid.org/0009-0004-3833-0184, Manu, Doina ORCID: https://orcid.org/0000-0001-8374-4977, Sawkulycz, Xenia, Caprio, Vittorio ORCID: https://orcid.org/0000-0002-9752-6513, Banescu, Claudia, Dobreanu, Minodora ORCID: https://orcid.org/0000-0003-3214-3631, Potempa, Lawrence ORCID: https://orcid.org/0000-0002-9267-1041, Di Napoli, Mario and Slevin, Mark ORCID: https://orcid.org/0000-0003-3767-4861 (2024) mCRP-Induced Focal Adhesion Kinase-Dependent Monocyte Aggregation and M1 Polarization, which was partially blocked by the C10M Inhibitor. International Journal of Molecular Sciences, 25 (6). 3097. ISSN 1661-6596

Preview

Published Version Available under License Creative Commons Attribution. Download (3MB) | Preview

Abstract

Monomeric C-reactive protein (mCRP) has recently been implicated in the abnormal vascular activation associated with development of atherosclerosis, but it may act more specifically through mechanisms perpetuating damaged vessel inflammation and subsequent aggregation and internalization of resident macrophages. Whilst the direct effects of mCRP on endothelial cells have been characterized, the interaction with blood monocytes has, to our knowledge, not been fully defined. Here we showed that mCRP caused a strong aggregation of both U937 cell line and primary peripheral blood monocytes (PBMs) obtained from healthy donors. Moreover, this increase in clustering was dependent on focal adhesion kinase (FAK) activation (blocked by a specific inhibitor), as was the concomitant adhesive attachment to the plate, which was suggestive of macrophage differentiation. Confocal microscopy confirmed the increased expression and nuclear localization of p-FAK, and cell surface marker expression associated with M1 macrophage polarization (CD11b, CD14, and CD80, as well as iNOS) in the presence of mCRP. Inclusion of a specific CRP dissociation/mCRP inhibitor (C10M) effectively inhibited PBMs clustering, as well as abrogating p-FAK expression, and partially reduced the expression of markers associated with M1 macrophage differentiation. mCRP also increased the secretion of pro-inflammatory cytokines Interleukin-8 (IL-8) and Interleukin-1β (IL-1β), without notably affecting MAP kinase signaling pathways; inclusion of C10M did not perturb or modify these effects. In conclusion, mCRP modulates PBMs through a mechanism that involves FAK and results in cell clustering and adhesion concomitant with changes consistent with M1 phenotypical polarization. C10M has potential therapeutic utility in blocking the primary interaction of mCRP with the cells—for example, by protecting against monocyte accumulation and residence at damaged vessels that may be predisposed to plaque development and atherosclerosis.